bucladesine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DH; Lerner, A | 1 |
| Dalloul, AH; Mentz, F; Merle-Beral, H | 1 |
2 other study(ies) available for bucladesine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Antibodies, Anti-Idiotypic; Antigens, CD19; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Bucladesine; Calcium; Calmodulin; Cells, Cultured; Colforsin; Cyclic AMP; DNA, Complementary; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Interleukin-2; Isoenzymes; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Phosphodiesterase Inhibitors; Polymerase Chain Reaction; Pyrrolidinones; RNA, Messenger; Rolipram; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vinca Alkaloids | 1998 |
Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, Differentiation; Apoptosis; B-Lymphocytes; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Dinoprostone; Humans; Immunophenotyping; Interleukin-10; Leukemia, Lymphocytic, Chronic, B-Cell; Membrane Glycoproteins; NAD+ Nucleosidase; Theophylline; Thionucleotides | 1999 |